Kairos Pharma Ltd (AMEX:KAPA)’s traded shares stood at 1.51 million during the last session. At the close of trading, the stock’s price was $1.77, to imply an increase of 34.09% or $0.45 in intraday trading. The KAPA share’s 52-week high remains $4.00, putting it -125.99% down since that peak but still an impressive 51.98% since price per share fell to its 52-week low of $0.85. The company has a valuation of $22.74M, with an average of 11.86 million shares in intraday trading volume over the past 10 days and average of 2.19 million shares over the past 3 months.
Kairos Pharma Ltd (AMEX:KAPA) trade information
After registering a 34.09% upside in the last session, Kairos Pharma Ltd (KAPA) has traded red over the past five days. The 5-day price performance for the stock is 71.84%, and 4.12% over 30 days. With these gigs, the year-to-date price performance is 16.45%. Short interest in Kairos Pharma Ltd (AMEX:KAPA) saw shorts transact 9605.0 shares and set a 0.13 days time to cover.
KAPA Dividends
Kairos Pharma Ltd has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
